A Study of Aducanumab in Participants With Mild Cognitive Impairment Due to Alzheimer's Disease or With Mild Alzheimer's Disease Dementia to Evaluate the Safety of Continued Dosing in Participants With Asymptomatic Amyloid-Related Imaging Abnorm
about
A Study of Aducanumab in Participants With Mild Cognitive Impairment Due to Alzheimer's Disease or With Mild Alzheimer's Disease Dementia to Evaluate the Safety of Continued Dosing in Participants With Asymptomatic Amyloid-Related Imaging Abnorm
description
clinical trial
@en
klinisch onderzoek
@nl
name
A Study of Aducanumab in Parti ...... Amyloid-Related Imaging Abnorm
@en
type
label
A Study of Aducanumab in Parti ...... Amyloid-Related Imaging Abnorm
@en
prefLabel
A Study of Aducanumab in Parti ...... Amyloid-Related Imaging Abnorm
@en
P17
P6153
P1476
A Phase 2, Multicenter, Random ...... -Related Imaging Abnormalities
@en
P1813
EVOLVE
@en
P3098
NCT03639987
P580
2018-12-20T00:00:00Z
P582
2021-07-09T00:00:00Z